NL-OMON34891已完成不适用
Clinical validation of the dried blood spot analysis for antituberculosis drugs - DBS analysis of anti-TB drugs
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Adult (>18 years old)
- •- TB-patient who using at least one of the following drugs: Isoniazid, Pyrazinamide, Rifampicin, Ethambutol, clarithromycin, Amikacin, Kanamycin, Moxifloxacin, Linezolid
- •- TB-patient who is scheduled for routine TDM by the doctor.
- •- written informed consent
排除标准
- •Patients with serious bleeding disorder
研究者
相似试验
已完成
不适用
Clinical validation of a dried blood spot (DBS) method for the analysis of immunosuppressive and antifungal drugs in pediatric patients (part of the PROTECT study).immuunsuppressie na niertransplantatieanalysis of drug used in renal transplantation / analysis of drug used in invasive fungal infections10017528NL-OMON44369Afdeling Apotheek89
撤回
不适用
Clinical validation of a dried blood spot (DBS) method for the analysis of rifampicin (RIBOD study).analysis of drugs used for tuberculosis10004018NL-OMON42070niversitair Medisch Centrum Sint Radboud10
招募中
不适用
Validation of dried blood spot sampling in therapeutic drug monitoring of cyclosporiTransplantation of hematopoetic stem cells or kidney10003816NL-OMON34000Vrije Universiteit Medisch Centrum40
已完成
不适用
Validation of dried blood spot sampling in therapeutic drug monitoring of nilotinibCancer of white blood cells10024324Chronic Myelogenous LeukemiaNL-OMON37855Vrije Universiteit Medisch Centrum40
已完成
不适用
Clinical validation of the Dry Blood Spot (DBS) method for risperidone, aripiprazole, pipamperone and its major metabolitesnvt10013511NL-OMON45799Erasmus MC, Universitair Medisch Centrum Rotterdam120